NO972222L - Bicykliske oxazin- og thiazinoxazolidinon-antibakterielle midler - Google Patents

Bicykliske oxazin- og thiazinoxazolidinon-antibakterielle midler

Info

Publication number
NO972222L
NO972222L NO972222A NO972222A NO972222L NO 972222 L NO972222 L NO 972222L NO 972222 A NO972222 A NO 972222A NO 972222 A NO972222 A NO 972222A NO 972222 L NO972222 L NO 972222L
Authority
NO
Norway
Prior art keywords
pct
date
spp
mycobacterium
oxazine
Prior art date
Application number
NO972222A
Other languages
English (en)
Norwegian (no)
Other versions
NO972222D0 (no
Inventor
Michael Robert Barbachyn
Richard Charles Thomas
Gary J Cleek
Lisa Marie Thomasco
Robert C Gadwood
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO972222D0 publication Critical patent/NO972222D0/no
Publication of NO972222L publication Critical patent/NO972222L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972222A 1994-11-15 1997-05-14 Bicykliske oxazin- og thiazinoxazolidinon-antibakterielle midler NO972222L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33997994A 1994-11-15 1994-11-15
PCT/US1995/012751 WO1996015130A1 (en) 1994-11-15 1995-10-31 Bicyclic oxazine and thiazine oxazolidinone antibacterials

Publications (2)

Publication Number Publication Date
NO972222D0 NO972222D0 (no) 1997-05-14
NO972222L true NO972222L (no) 1997-05-14

Family

ID=23331388

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972222A NO972222L (no) 1994-11-15 1997-05-14 Bicykliske oxazin- og thiazinoxazolidinon-antibakterielle midler

Country Status (17)

Country Link
US (1) US5952324A (de)
EP (1) EP0792273B1 (de)
JP (1) JPH10508844A (de)
KR (1) KR100392216B1 (de)
CN (1) CN1046520C (de)
AT (1) ATE233766T1 (de)
AU (1) AU702733B2 (de)
BR (1) BR9509673A (de)
DE (1) DE69529838T2 (de)
DK (1) DK0792273T3 (de)
ES (1) ES2193201T3 (de)
MX (1) MX9703543A (de)
NO (1) NO972222L (de)
NZ (1) NZ295528A (de)
PT (1) PT792273E (de)
RU (1) RU2128660C1 (de)
WO (1) WO1996015130A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214546T3 (es) * 1995-09-15 2004-09-16 PHARMACIA & UPJOHN COMPANY N-oxidos de aminoariloxazolidinona.
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
DK1114819T3 (da) * 1996-04-11 2008-04-14 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
KR100307211B1 (ko) * 1997-05-24 2001-11-30 손 경 식 옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
KR100467309B1 (ko) * 1997-09-04 2005-07-18 씨제이 주식회사 옥사졸리디논유도체및그의제조방법및항균제조성물
KR100463111B1 (ko) * 1997-10-30 2005-06-13 씨제이 주식회사 신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
SK18362000A3 (sk) 1998-06-05 2001-06-11 Astrazeneca Ab Oxazolidinónové deriváty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
EA005567B1 (ru) * 1999-12-21 2005-04-28 Фармация Энд Апджон Компани Оксазолидиноны, обладающие сульфоксиминовой функциональностью
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
EP1328509B1 (de) 2000-10-17 2006-03-22 Pharmacia & Upjohn Company LLC Verfahren zur herstellung von oxazolidinonverbindungen
EP1385844B1 (de) * 2001-04-07 2006-07-05 Astrazeneca AB Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
DE60222645T2 (de) * 2001-04-20 2008-07-17 Pharmacia & Upjohn Co. Llc, Kalamazoo Verfahren zur herstellung von oxazolidinonen
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
JP2005527575A (ja) * 2002-03-29 2005-09-15 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 糖尿病性足病変感染を治療するためのオキサゾリジノンの非経口、静脈内および経口投与
ATE321760T1 (de) * 2002-08-12 2006-04-15 Pharmacia & Upjohn Co Llc N-aryl-2-oxazolidinone und deren derivate
AR042086A1 (es) * 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
EP1594865A2 (de) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Antibakterielle mittel
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりn−置換されたオキサゾリジノン誘導体
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US20070004679A1 (en) * 2004-05-17 2007-01-04 Nathalie Schlienger Androgen receptor modulators and methods of treating disease using the same
AU2005247405A1 (en) * 2004-05-17 2005-12-08 Acadia Pharmaceuticals Inc. Androgen receptor modulators and method of treating disease using the same
US20050261278A1 (en) * 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
WO2006016220A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxindole oxazolidinones as antibacterial agents
EP2302078B1 (de) 2004-11-03 2015-07-15 Iris Molecular Diagnostics, Inc. Mikrobläschen zur Konzentration mittels Affinitätstrennung
CA2585781A1 (en) 2004-11-03 2006-12-28 Iris Molecular Diagnostics, Inc. Homogeneous analyte detection
CN101119993B (zh) * 2005-01-10 2015-03-04 阿卡蒂亚药品公司 作为选择性雄激素受体调节剂的氨基苯基衍生物
US20060173037A1 (en) * 2005-01-10 2006-08-03 Nathalie Schlienger Aminophenyl derivatives as selective androgen receptor modulators
EP1899331B1 (de) 2005-06-29 2009-11-25 Pharmacia & Upjohn Company LLC Homomorpholinoxazolidinone als antibakterielle mittel
CA2712613C (en) * 2008-03-26 2017-02-28 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
KR20180022826A (ko) 2015-07-02 2018-03-06 얀센 사이언시즈 아일랜드 유씨 항균 화합물
ES2897973T3 (es) * 2015-07-17 2022-03-03 The Global Alliance For Tb Drug Dev Inc Feniloxazolidinonas sustituidas para terapia antimicrobiana
MX2018015656A (es) 2016-06-16 2019-03-14 Janssen Sciences Ireland Unlimited Co Compuestos heterociclicos como antibacterianos.
US11224596B2 (en) 2017-03-01 2022-01-18 Janssen Sciences Ireland Unlimited Company PZA and cytochrome bc1 inhibitor combination treatment
WO2020147504A1 (en) * 2019-01-18 2020-07-23 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
EP0316594B1 (de) * 1987-10-21 1993-09-29 The Du Pont Merck Pharmaceutical Company Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0434714A1 (de) * 1988-09-15 1991-07-03 The Upjohn Company In stellung3-substituierte 5-beta-amidomethyloxazolinden-2-on-derivate
EP0610265B1 (de) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituierte aryl- und heteroaryl-phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CA2174107C (en) * 1993-11-22 2005-04-12 Steven J. Brickner Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU702733B2 (en) 1999-03-04
WO1996015130A1 (en) 1996-05-23
DE69529838D1 (de) 2003-04-10
BR9509673A (pt) 1997-09-30
CN1163615A (zh) 1997-10-29
RU2128660C1 (ru) 1999-04-10
NO972222D0 (no) 1997-05-14
DK0792273T3 (da) 2003-06-16
AU3889095A (en) 1996-06-06
MX9703543A (es) 1997-08-30
ES2193201T3 (es) 2003-11-01
PT792273E (pt) 2003-06-30
CN1046520C (zh) 1999-11-17
KR100392216B1 (ko) 2003-10-17
JPH10508844A (ja) 1998-09-02
NZ295528A (en) 1999-03-29
ATE233766T1 (de) 2003-03-15
EP0792273B1 (de) 2003-03-05
DE69529838T2 (de) 2003-11-13
EP0792273A1 (de) 1997-09-03
US5952324A (en) 1999-09-14

Similar Documents

Publication Publication Date Title
DK0792273T3 (da) Bicycliske oxazin- og thiazin-oxazolidinon-antibakterielle midler
ES2162941T3 (es) Compuestos antimicrobianos de feniloxazolidinona.
LV12605A (en) Substituted oxazine and thiazine oxazlidinone antimicrobials
DK0874852T3 (da) Antibakterielt oxazolidinonmiddel med tricykliske substituenter
EP1409464A4 (de) Oxazolidinonderivate als potentielle antimikrobielle mittel
MX9703040A (es) Antimicrobianos de feniloxazolidinona.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application